查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1601142

器官移植市场：按类型、最终用户分类 - 2025-2030 年全球预测

Organ Transplantation Market by Type (Heart Transplantation, Kidney Transplantation, Liver Transplantation), End User (Hospitals & Care Providers, Transplant Centers) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年器官移植市值为164.5亿美元，预计2024年将达到180.7亿美元，复合年增长率为10.30%，到2030年将达到326.9亿美元。

器官移植市场的范围和定义包括将器官从体内取出并移植到接受者体内的外科手术。由于糖尿病、心臟病和肾臟病等慢性疾病的增加，对器官移植的需求不断增加。应用包括心臟移植、肝臟移植、肾臟移植、肺移植和胰臟移植，最终用途包括医院、移植中心和研究机构。该市场受到器官衰竭盛行率增加、手术技术进步、免疫抑制药物改进以及对器官捐赠的认识和承诺不断增强等因素的显着影响。

主要市场统计
基准年[2023] 164.5亿美元
预测年份 [2024] 180.7亿美元
预测年份 [2030] 326.9亿美元
复合年增长率（%） 10.30%

最新的潜在机会来自生物工程和再生医学等技术进步，这些技术进步解决了器官供不应求和排斥併发症的限制。器官保存技术的创新和人造器官的开发代表了一条利润丰厚的前进道路。不断增长的市场面临器官排斥风险、伦理问题、高成本和严格的法律规范等限制，这些仍然是挑战。此外，器官供需之间的差距继续阻碍市场扩张。

为了利用成长机会，相关人员应专注于异种移植和干细胞治疗的创新研究，这有可能扩大器官供应。促进器官捐赠登记和公共教育宣传活动可以提高捐赠率并进一步支持市场开拓。此外，探索个人化医疗来调整免疫抑制方案可以提高移植成功率。毕竟，市场动态是动态的，不断的研究和创新努力可以解决器官短缺问题并改善患者的治疗结果，从而推动市场的发展。

市场动态：揭示快速发展的器官移植市场的关键市场洞察

供需的动态交互作用正在改变器官移植市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 器官移植手术数量增加
    • 慢性疾病增加和器官衰竭加速
    • 开拓器官捐赠与移植合法化管道
  • 市场限制因素
    • 器官捐赠者短缺和治疗费用上涨
  • 市场机会
    • 器官移植方法的技术进步
    • 器官捐赠意识不断增强
  • 市场问题
    • 器官移植的社会与伦理问题

波特五力：驾驭器官移植市场的策略工具

波特的五力框架是了解器官移植市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点，避免潜在的挑战，确保更强大的市场地位。

PESTLE分析：了解器官移植市场的外部影响

外部宏观环境因素在塑造器官移植市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解器官移植市场的竞争状况

器官移植市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：器官移植市场供应商绩效评估

FPNV定位矩阵是评估器官移植市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

该报告提供了涵盖关键焦点细分市场的全面市场分析。

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 器官移植手术数量增加
      • 慢性疾病和器官衰竭的增加
      • 开拓器官捐赠与移植的合法管道
    • 抑制因素
      • 器官捐赠者短缺和治疗费用上涨
    • 机会
      • 器官移植技术的技术进步
      • 意识提升
    • 任务
      • 器官移植的社会与伦理问题
  • 市场区隔分析
    • 类型：由于肾臟疾病增加导致肾臟移植迅速增加
    • 最终用户：人员和技术的专业化推动移植中心的器官移植
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境
  • 客户客製化

第六章 器官移植市场：依类型

  • 介绍
  • 心臟移植
  • 肾臟移植
  • 肝臟移植
  • 肺移植
  • 胰臟移植

第七章 器官移植市场：依最终使用者分类

  • 介绍
  • 医院和护理提供者
  • 移植中心

第八章美洲器官移植市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太器官移植市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲器官移植市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • TransMedics 签署收购 Summit Aviation 的最终协议，扩大 TransMedics 器官移植航空能力
    • LiveOnNY 和 MediGO 合作推出即时器官追踪技术，提高器官捐赠和移植生态系统的透明度和课责
    • 泛美卫生组织和西班牙签署协议加强美洲器官捐赠和移植

公司名单

  • Illumina, Inc.
  • Veloxis Pharmaceuticals, Inc. by Asahi Kasei Corp.
  • Artivion, Inc.
  • Thermo Fisher Scientific Inc.
  • Pfizer Inc.
  • OrganOx Limited
  • Organovo Holdings, Inc.
  • Arthrex, Inc.
  • 21st Century Medicine
  • Exactech, Inc.
  • CHIESI Farmaceutici SpA by Amryt Pharma PLC
  • Xvivo Perfusion AB
  • Sanofi SA
  • BiolifeSolutions, Inc.
  • Dr. Franz Kohler Chemie GmbH
  • Teva Pharmaceuticals Industries Ltd.
  • Preservation Solutions, Inc.
  • F. Hoffmann-La Roche Ltd
  • Organ Recovery Systems
  • Medtronic PLC
  • Astellas Pharma Inc.
  • Stryker Corporation
  • Novartis AG
  • NHS Blood and Transplant
  • TransMedics Group, Inc.
  • Plexision
  • AbbVie Inc.
  • Bio-Rad Laboratories, Inc.
Product Code: MRR-437896AA3BAA

The Organ Transplantation Market was valued at USD 16.45 billion in 2023, expected to reach USD 18.07 billion in 2024, and is projected to grow at a CAGR of 10.30%, to USD 32.69 billion by 2030.

The scope and definition of the organ transplantation market encompass the surgical procedure where an organ is removed from one body and placed in the body of a recipient, often necessitated by the failure or non-functionality of the recipient's organ. The necessity of organ transplantation is increasingly critical due to rising incidences of chronic diseases like diabetes, heart disease, and kidney disorders, which often require such interventions. Application-wise, it spans heart, liver, kidney, lung, and pancreas transplants, with end-use scope including hospitals, transplant centers, and research organizations. The market is significantly influenced by factors such as the growing prevalence of organ failure, advancements in surgical techniques, improved immunosuppressive drugs, and increasing awareness and initiatives towards organ donation.

KEY MARKET STATISTICS
Base Year [2023] USD 16.45 billion
Estimated Year [2024] USD 18.07 billion
Forecast Year [2030] USD 32.69 billion
CAGR (%) 10.30%

Latest potential opportunities arise from technological advancements like bioengineering and regenerative medicine, addressing the limitations posed by organ supply shortages and rejection complications. Innovation in organ preservation techniques and development of artificial organs offers lucrative avenues. Despite the growth prospects, the market faces limitations such as organ rejection risks, ethical concerns, high costs, and stringent regulatory frameworks, which remain challenging factors. Furthermore, the disparity between organ demand and supply continues to hinder market expansion.

To harness growth opportunities, stakeholders should focus on innovative research in xenotransplantation and stem cell therapy, which hold promise for extending the organ supply. Advancing organ donor registration systems and public education campaigns can stimulate donor rates, further supporting market development. Additionally, exploring personalized medicine to tailor immunosuppressive regimens can enhance transplantation success rates. Ultimately, the organ transplantation market is dynamic and driven by continuous research and innovation efforts to address organ scarcity and enhance patient outcomes, indicating a significant potential for business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Organ Transplantation Market

The Organ Transplantation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing Number of Organ Transplantation Surgeries
    • Increasing Prevalence of Chronic Diseases and Accelerating Cases of Organ Failure
    • Development of Legalized Channel for Organ Donors and Transplants
  • Market Restraints
    • Shortage of Organ Donors and High Cost of Treatment
  • Market Opportunities
    • Technological Advancement in Organ Transplantation Methods
    • Increasing Awareness of Organ Donation
  • Market Challenges
    • Social and Ethical Concerns in Organ Transplantation

Porter's Five Forces: A Strategic Tool for Navigating the Organ Transplantation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Organ Transplantation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Organ Transplantation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Organ Transplantation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Organ Transplantation Market

A detailed market share analysis in the Organ Transplantation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Organ Transplantation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Organ Transplantation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Organ Transplantation Market, highlighting leading vendors and their innovative profiles. These include Illumina, Inc., Veloxis Pharmaceuticals, Inc. by Asahi Kasei Corp., Artivion, Inc., Thermo Fisher Scientific Inc., Pfizer Inc., OrganOx Limited, Organovo Holdings, Inc., Arthrex, Inc., 21st Century Medicine, Exactech, Inc., CHIESI Farmaceutici S.p.A. by Amryt Pharma PLC, Xvivo Perfusion AB, Sanofi S.A., BiolifeSolutions, Inc., Dr. Franz Kohler Chemie GmbH, Teva Pharmaceuticals Industries Ltd., Preservation Solutions, Inc., F. Hoffmann-La Roche Ltd, Organ Recovery Systems, Medtronic PLC, Astellas Pharma Inc., Stryker Corporation, Novartis AG, NHS Blood and Transplant, TransMedics Group, Inc., Plexision, AbbVie Inc., and Bio-Rad Laboratories, Inc..

Market Segmentation & Coverage

This research report categorizes the Organ Transplantation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Heart Transplantation, Kidney Transplantation, Liver Transplantation, Lung Transplantation, and Pancreas Transplantation.
  • Based on End User, market is studied across Hospitals & Care Providers and Transplant Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Number of Organ Transplantation Surgeries
      • 5.1.1.2. Increasing Prevalence of Chronic Diseases and Accelerating Cases of Organ Failure
      • 5.1.1.3. Development of Legalized Channel for Organ Donors and Transplants
    • 5.1.2. Restraints
      • 5.1.2.1. Shortage of Organ Donors and High Cost of Treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological Advancement in Organ Transplantation Methods
      • 5.1.3.2. Increasing Awareness of Organ Donation
    • 5.1.4. Challenges
      • 5.1.4.1. Social and Ethical Concerns in Organ Transplantation
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Burgeoning kidney transplantation due to the increasing incidence of kidney diseases
    • 5.2.2. End User: Evolving organ transplantation in transplant centers owing to the specialization of staff and the technology
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Organ Transplantation Market, by Type

  • 6.1. Introduction
  • 6.2. Heart Transplantation
  • 6.3. Kidney Transplantation
  • 6.4. Liver Transplantation
  • 6.5. Lung Transplantation
  • 6.6. Pancreas Transplantation

7. Organ Transplantation Market, by End User

  • 7.1. Introduction
  • 7.2. Hospitals & Care Providers
  • 7.3. Transplant Centers

8. Americas Organ Transplantation Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Organ Transplantation Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Organ Transplantation Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. TransMedics Signs Definitive Agreement to Acquire Summit Aviation to Expand TransMedics Aviation Capabilities for Organ Transplantation
    • 11.3.2. LiveOnNY and MediGO Collaborate to Launch Real-Time Organ Tracking Technology to Increase Transparency and Accountability Within the Organ Donation and Transplant Ecosystem
    • 11.3.3. PAHO and Spain Sign Agreement to Strengthen Organ Donation and Transplant in the Americas

Companies Mentioned

  • 1. Illumina, Inc.
  • 2. Veloxis Pharmaceuticals, Inc. by Asahi Kasei Corp.
  • 3. Artivion, Inc.
  • 4. Thermo Fisher Scientific Inc.
  • 5. Pfizer Inc.
  • 6. OrganOx Limited
  • 7. Organovo Holdings, Inc.
  • 8. Arthrex, Inc.
  • 9. 21st Century Medicine
  • 10. Exactech, Inc.
  • 11. CHIESI Farmaceutici S.p.A. by Amryt Pharma PLC
  • 12. Xvivo Perfusion AB
  • 13. Sanofi S.A.
  • 14. BiolifeSolutions, Inc.
  • 15. Dr. Franz Kohler Chemie GmbH
  • 16. Teva Pharmaceuticals Industries Ltd.
  • 17. Preservation Solutions, Inc.
  • 18. F. Hoffmann-La Roche Ltd
  • 19. Organ Recovery Systems
  • 20. Medtronic PLC
  • 21. Astellas Pharma Inc.
  • 22. Stryker Corporation
  • 23. Novartis AG
  • 24. NHS Blood and Transplant
  • 25. TransMedics Group, Inc.
  • 26. Plexision
  • 27. AbbVie Inc.
  • 28. Bio-Rad Laboratories, Inc.

LIST OF FIGURES

  • FIGURE 1. ORGAN TRANSPLANTATION MARKET RESEARCH PROCESS
  • FIGURE 2. ORGAN TRANSPLANTATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ORGAN TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ORGAN TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ORGAN TRANSPLANTATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ORGAN TRANSPLANTATION MARKET DYNAMICS
  • TABLE 7. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY HEART TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY KIDNEY TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY LIVER TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY LUNG TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY PANCREAS TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TRANSPLANT CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. ORGAN TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. ORGAN TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2023